Abbott's salespersons corrupt quack doctors, leading to unnecessary prescriptions and deaths
Superbugs are commonly known as bacteria that could resist medicines and happens due to unregulated usage of antibiotics. About a million people across the globe die due to superbugs and could reach to 10 million by 2050, if not properly treated1. A study conducted on 4,437 hospitalized patients in 2015 revealed that India has the highest mortality rate of 13% (581) due to drug-resistant superbugs2. Also, they kill approx. 58,000 babies a year across India3.
Abbott used 3,748,611 MWh of energy in 2019, equal to the annual electricity usage of 448,732 homes
In 2020, the United States consumed 27 billion MWh of energy, of which renewable energy accounted for about 11%, and the remaining 89% of the energy was from non-renewable resources1. Non-renewable energy sources increase the GHG gases, thereby altering the atmosphere of the earth2.
Abbott Laboratories paid US$25 million to settle bribery allegations to prescribe TriCor in 2018
According to ProPublica, between 2014 and 2018, pharmaceutical companies spent approximately $2.1 billion to $2.2 billion paying doctors for prescribing and recommending their drugs and devices. Roughly, over 600,000 doctors receive payment from pharmaceutical companies each year3. Big Pharma companies are known to bribe physicians to prescribe their drugs13.
Abbott is helping to make roads safer by bringing leading technology for drug testing
Part of the SDG´s goals is to reduce the number of global deaths and injuries from road traffic accidents. 1 As marijuana legalization gathers momentum, especially in the U.S. and Canada, legislators and police officers are committed to keeping roads safe from the growing problem of drug-impaired drivers. According to a 2016 report, the number of drug-related driving deaths in the U.S has risen by more than 50 percent compared to a decade ago, and one-third of respondents (33%) personally know someone who has driven a car soon after taking drugs. 2,3
Abbott has delivered 2 billion diagnostic tests in 2018
The early diagnosis of diseases with high accuracy play a critical role in the patient’s treatment. Without using any specialized laboratory, the capability to diagnose a condition has quickly transformed the accessibility to healthcare. Abbott, with its rapid diagnostics business, has made the point of care (POC) testing services available around the world.